KalVista Pharmaceuticals, Inc.

KALV · Nasdaq · SIC 2834: Pharmaceutical Preparations
193
SEC Filings

Business Summary

4 Item 1A. Risk Factors 22 Item 1B. Unresolved Staff Comments 57 Item 1C. Cybersecurity 57 Item 2. Properties 58 Item 3. Legal Proceedings 59 Item 4. Mine Safety Disclosures 59 PART II Item 5. Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 60 Item 6. Reserved 60 Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations 61 Item 7A. Quantitative and Qualitative Disclosures About Market Risk 67 Item 8. F...

Next Earnings

Q2 FY2026 — expected 2026-09-15

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionKALVdiscussed_in_filing Cybersecurity
topic_mentionKALVdiscussed_in_filing Cybersecurity
topic_mentionKALVdiscussed_in_filing Cybersecurity
topic_mentionKALVdiscussed_in_filing Cybersecurity

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2025-07-102025-04-300000950170-25-095011EDGAR67K words
2024-07-112024-04-300000950170-24-082965EDGAR—
2023-07-102023-04-300000950170-23-032298EDGAR—
2022-07-072022-04-300000950170-22-012521EDGAR—
2021-07-132021-04-300001564590-21-036441EDGAR—
2020-07-012020-04-300001564590-20-031501EDGAR—
2019-07-162019-04-300001564590-19-025009EDGAR—
2018-07-302018-04-300001564590-18-017915EDGAR—
2017-07-272017-04-300001564590-17-014286EDGAR—
2016-03-302015-12-310001564590-16-015646EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-102025-09-300001193125-25-274442EDGAR18K words
2025-09-112025-07-310001193125-25-200757EDGAR—
2025-03-122025-01-310000950170-25-037995EDGAR—
2024-12-052024-10-310000950170-24-133673EDGAR—
2024-09-052024-07-310000950170-24-103981EDGAR—
2024-03-112024-01-310000950170-24-029314EDGAR—
2023-12-072023-10-310000950170-23-068801EDGAR—
2023-09-072023-07-310000950170-23-047008EDGAR—
2023-03-092023-01-310000950170-23-007020EDGAR—
2022-12-082022-10-310000950170-22-026230EDGAR—
2022-09-082022-07-310000950170-22-018239EDGAR—
2022-03-102022-01-310000950170-22-003361EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-250001193125-26-122784EDGAR2K words
2026-01-080001193125-26-007801EDGAR—
2025-11-100001193125-25-274405EDGAR—
2025-10-060001193125-25-230906EDGAR—
2025-10-020001193125-25-227478EDGAR—
2025-09-290001193125-25-223262EDGAR—
2025-09-110001193125-25-200742EDGAR—
2025-08-210001193125-25-185382EDGAR—
2025-07-100001193125-25-157382EDGAR—
2025-07-070001193125-25-155885EDGAR—

193 total filings indexed. 161 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001348911
TickerKALV
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 6f1aeed093aee8a5063532af165da56266abd146aba828c9c368f92995aeecfa
parent: c5cf85ecb6ad37bf33a8d71f454bf2cd0774443494d665ad9889cc1eae98dd7e
content hash: 083c6d9fa7b37b09cb61eeccb21bf7936508c67ad19129eadc523ce1b30615a1
signed: 2026-04-13T04:45:51.224Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf